In another study, Powe et al2 found that GDM subtypes with predominant defects in insulin sensitivity had a higher risk of GDM‐associated adverse pregnancy outcomes as well as larger infants as compared to patients with predominant defects in insulin secretion or women with NGT. The gene discussed is INS; the disease is gestational diabetes.